To combat the mounting debt, Tulsi Tanti pursued a bold financial restructuring. He negotiated with banks to convert loans into foreign currency convertible bonds, agreeing to monetize assets to repay the debt. True to his word, Suzlon sold Senvion to Centerbridge Capital for Rs 7,500 crore. The infusion of funds provided the lifeline Suzlon needed to stabilize. Tanti also secured a strategic investment of Rs 400 crore from Sun Pharma's Dilip Shanghvi, establishing a joint venture that ensured Suzlon's operations could continue uninterrupted. The efforts paid off: by 2020, Suzlon's debt had decreased to Rs 4,453 crore, setting the stage for a remarkable turnaround.